Growth momentum expected to hold; rising cost inflation the margin wild card
Anand Rathi's equity broker hit 22% revenue growth in Q1 FY27 tracking guidance. For Q2, Street watches whether growth holds through quarter-end while cost pressures test EBITDA leverage. NCD fundraise signals balance-sheet optimization for UAE expansion.
What to expect: revenue in the groove, margins tested
Anand Rathi delivered ₹2,461 million in Q1 FY27, up 22.4% year-on-year and comfortably inside the company's guidance corridor of 15–25% growth. For Q2, Street consensus narrows to expecting on-plan revenue in the ₹2,500–2,800 Mn range—the cadence holding as broking, margin funding, and distribution channels all track steady. The real test is margin defence: EBITDA margin expanded to 39.5% in Q1 from 37.2% prior-year, but recent commentary flags rising input costs and wage inflation as Q2 headwinds, potentially compressing that gain.
₹2,461 Mn
up 22.4% YoY; within 15–25% FY27 guidance
~₹2,500–2,800 Mn
sustaining growth momentum; on-plan
39.5% (Q1)
up from 37.2% YoY but cost inflation poses headwind
~30–35%
Q1 PAT ₹390.6 Mn (+71.2%); Q2 ~₹500–520 Mn on-plan
A strong Q2 means the company delivers revenue in the ₹2,600–2,800 Mn band, holds EBITDA margin above 38.5%, and reports PAT at or above ₹500 Mn—confirming that broking volume growth and margin funding book expansion are withstanding cost inflation. A weak print would see revenue below ₹2,500 Mn (trend stall), EBITDA margin compression below 37.5% (cost bleed), or PAT growth slowing to below 25% YoY (operational leverage breakdown). The pivot is the non-broking revenue mix: if distribution AUM and lending income hold momentum, margins stay supported; if those plateau, cost inflation flows straight to the bottom line.
On track with FY27 guidance
Anand Rathi set two clear FY27 targets: revenue growth of 15–25% and PAT growth of 30–35%. Q1 delivered 22.4% revenue growth and a 71.2% surge in PAT (before exceptional items), signalling strong execution and margin expansion. The company is targeting a 50:50 broking/non-broking revenue mix by 2027, a structural shift that requires sustained distribution AUM inflows and margin funding growth. Margin funding book surged 26% quarter-on-quarter in Q2 FY26, and the broking-to-lending ratio has stayed disciplined. If Q2 posts revenue in the ₹2,500–2,800 Mn range (15–25% YoY growth) and PAT around ₹500–520 Mn, the company stays on pace to deliver full-year targets—though cost pressures could trim upside by 100–150 bps of margin.
What the Street says
Since last quarter: filings scan
1 · Debt raise in play
On July 14, the Board approved a ₹500 Cr NCD issuance mandate (up to ₹500 Cr). Allotments followed: ₹10.85 Cr (Sept 28), ₹11.4 Cr (Aug 27), ₹4.5 Cr (July 29), ₹1 Cr (Sept 10)—a total of ₹27.75 Cr deployed in 3 months. Signals balance-sheet optimization; deployed capital likely fuels UAE subsidiary expansion and margin funding book growth. Routine.
2 · UAE subsidiary incorporation approved
July 14 Board approval to incorporate a wholly-owned subsidiary in Dubai, UAE. Part of the company's international expansion strategy. No material revenue expected in H1 FY27, but positions the group for flow-picking and regional wealth management. Structural positive.
3 · Legal win: ₹4.93 Cr arbitral award quashed
July 17: Bombay High Court quashed an arbitral award of ₹4.93 Cr + interest that had been previously disclosed. Removes a contingent liability from the balance sheet. One-time positive; no recurring impact.
4 · FII/DII ownership trend softening
Q1 FY27: FII 0.15% (vs. 1.91% in Q3 FY26), DII 4.06% (vs. 6.09% in Q3 FY26). Both down nearly 2 percentage points. Promoters holding steady at 69.62%. Flow weakness likely reflects profit-taking post-IPO and broad FII caution. Sentiment flag; not fundamental.
5 · Insider trading window closed
Sept 23: Trading window closed Oct 1 for result disclosure. Standard regulatory compliance. Routine.
The setup and what to watch
Anand Rathi sits at an inflection: a young public broker with strong revenue momentum (22% in Q1, guidance 15–25%), widening margins (EBITDA 39.5%), and a strategic pivot toward non-broking income (distribution, lending) that could unlock 30–35% PAT growth for the cycle. But Q2 is where cost inflation lands—wage pressures, tech spend for platform scale, and regulatory compliance all squeeze EBITDA leverage. The Street expects the company to post on-plan revenue (₹2,500–2,800 Mn) and hold margins above 38%, but misses on either front would trigger a re-rate lower.
Result day (Oct 13) watch list: (1) Revenue breakdown—does broking stay resilient, and does margin funding/ distribution AUM growth offset any seasonal softness? (2) EBITDA margin—can the company hold 38%+, or does cost inflation push it below 37.5%? (3) PAT growth—does PAT stay north of ₹500 Mn, validating the 30–35% FY27 target, or slow below? (4) Management commentary—color on market share wins (broking seats, margin funding exposure, AUM inflows) and cost trajectory through H2. (5) Balance sheet—how much of the NCD proceeds have been deployed, and what is the capital-expenditure outlook for the UAE subsidiary?